<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Bio-Line from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Bio-Line news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 04:39:25 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Bio-Line" rel="self" type="application/rss+xml" />

	
<item><title>Three Questions Facing the Future of Compugen</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4039513&amp;HITNO=0&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4039513&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538170631%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4039513&amp;HITNO=0&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4039513&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2538170631%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>World Market Media:</description></item>
<item><title>'Revolutionary' Water Treatment Units on Their Way to Afghanistan, Maybe Haiti</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038871&amp;HITNO=1&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038871&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537814774%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038871&amp;HITNO=1&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038871&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537814774%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Freshnews.com:</description></item>
<item><title>Mescal 'worm' test shows DNA leaks into preservatives</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038998&amp;HITNO=2&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038998&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537866424%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038998&amp;HITNO=2&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038998&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537866424%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Research &amp; Development:</description></item>
<item><title>Mescal 'worm' test shows DNA leaks into preservatives</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038935&amp;HITNO=3&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038935&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537841495%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038935&amp;HITNO=3&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038935&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537841495%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>EurekAlert!:</description></item>
<item><title>BioAlliance Pharma Announces Its Consolidated Turnover for 2009 a Doubling in Recurring Revenues</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036744&amp;HITNO=4&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036744&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536732985%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036744&amp;HITNO=4&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036744&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536732985%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>BioAlliance Pharma Announces Its Consolidated Turnover for 2009 a Doubling in Recurring Revenues</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036743&amp;HITNO=5&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036743&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536732789%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036743&amp;HITNO=5&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036743&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536732789%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
<item><title>UPDATE 1-Gilead sees big potential in new HIV pill</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037213&amp;HITNO=6&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037213&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536965824%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037213&amp;HITNO=6&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037213&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536965824%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Sharenet:</description></item>
<item><title>INTERVIEW-Gilead sees big potential in new HIV pill</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036976&amp;HITNO=7&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036976&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536851540%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036976&amp;HITNO=7&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036976&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536851540%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>CNN Money:</description></item>
<item><title>News and FDA Updates for AdvanSource (NYSE:ASB), Advaxis (OTC:ADXS), Alnylam (Nasdaq:ALNY)</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035382&amp;HITNO=8&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035382&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536218868%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035382&amp;HITNO=8&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035382&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536218868%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Los Angeles Chronicle:</description></item>
<item><title>UDATE 1-NeurogesX sees 'mid-tier' pain-patch price</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032335&amp;HITNO=9&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032335&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534607077%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032335&amp;HITNO=9&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032335&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534607077%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Sharenet:</description></item>
<item><title>Let's make a deal</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032800&amp;HITNO=10&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032800&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534824437%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032800&amp;HITNO=10&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032800&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534824437%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Drug Discovery News:</description></item>
<item><title>Karo Bio: Year-End Report January-December 2009</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033723&amp;HITNO=11&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033723&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535355550%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033723&amp;HITNO=11&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033723&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535355550%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Yahoo! Canada:</description></item>
<item><title>BIO Joins Stakeholders In Expressing Concerns With Efforts To Restrict Gene Patenting</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033033&amp;HITNO=12&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033033&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534955550%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033033&amp;HITNO=12&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033033&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534955550%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>MediLexicon:</description></item>
<item><title>NexMed closes acquisition of Bio-Quant</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032778&amp;HITNO=13&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032778&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534820847%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4032778&amp;HITNO=13&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4032778&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2534820847%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Drug Discovery News:</description></item>
<item><title>BIO-key launches biometric user identity software</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033528&amp;HITNO=14&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033528&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535250796%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4033528&amp;HITNO=14&amp;MSIZE=1000&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Bio-Line&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4033528&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535250796%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Computer Business Review:</description></item>
</channel></rss>